July 20, 2021   USA
bioprocessonline.com: A Vaccine For Type 1 Diabetes With Diamyd Medical's Dr. Ulf Hannelius

On this week's episode of The Business of Biotech, Diamyd Medical President & CEO Dr. Ulf Hannelius tells us all about the therapies his company is developing, plus the why and the how behind the company's choice to manufacture them in-house.

Listen to the podcast here

Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research